IP Library Granted Patent US 8,975,242
Granted Patent B2
US 8,975,242 · App. 13/011,164 · Granted Mar 10, 2015

Tigecycline compositions and methods of preparation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,975,242
App. No.
13/011,164
Granted
Mar 10, 2015
Kind
B2
Abstract

The present invention relates to novel tigecycline compositions with improved stability in both solid and solution states and processes for making these compositions. These compositions comprise tigecycline, a suitable carbohydrate, and an acid or buffer.

Claims (10)

1. A composition comprising tigecycline, lactose, and an acid, wherein the molar ratio of tigecycline to lactose is between about 1:1.6 to about 1:3.3, and the pH of the composition in a solution is between about 4.0 and about 5.0, wherein the acid is hydrochloric acid, and the composition further comprises tigecycline epimer in an amount that is not more than 2.56% as measured after storage of the composition at about 40° C. and 75% relative humidity for not more 39 days.

2. The composition of claim 1 , wherein the composition is lyophilized.

3. The composition according to claim 1 further comprising a pharmaceutically acceptable diluent.

4. The composition according to claim 3 , wherein the pharmaceutically acceptable diluent is water, a saline, Lactated Ringer's Injection solution, or dextrose solution.

5. The composition of claim 1 , wherein the pH of the composition in a solution is between 4.2 and about 4.8.

6. A process for preparing a tigecycline composition comprising combining lactose with tigecycline and water to form a solution; reducing the pH of the solution with hydrochloric acid to between about 4.0 and about 5.0; and lyophilizing the solution to dryness to prepare a lyophilized composition;

wherein the lactose is capable of reducing epimer formation of tigecycline whereby the lyophilized composition further comprises tigecycline epimer in an amount that is not more than 2.56% as measured after storage of the lyophilized composition at about 40° C. and 75% relative humidity for not more 39 days, and the molar ratio of tigecycline to lactose is between about 1:1.6 to about 1:3.3.

7. The process of claim 6 further comprising combining the composition with a saline, Lactated Ringer's Injection solution or dextrose solution.

8. The process of claim 6 , wherein a solid is formed.

9. The process of claim 6 , wherein the pH of the solution is reduced to between about 4.2 and about 4.8.

Assignments (1)
ASSIGNEE ADDRESS CORRECTION Recorded Mar 27, 2023
From: WYETH LLC
To: WYETH LLC
Reel/Frame 063165/0455 →